Ahmedabad: Sales of cancer drugs in Gujarat have witnessed a sharp surge over the past year, outpacing the gradual rise in ...
Pharmaceutical Technology on MSN

Roche pens $490M Astex breast cancer license deal

Roche’s breast cancer agreement with Astex is one of several oncology deals the Swiss pharma giant has inked in recent years.
Phesgo is the name of an injection that contains both trastuzumab and pertuzumab. It is a type of targeted cancer drug. You pronounce Phesgo as fes-goh. You pronounce trastuzumab as tras-too-zoo-mab ...
US Food and Drug Administration (FDA) approved Ibrance (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of adult patients ...
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s PFE Ibrance (palbociclib) regimen for frontline maintenance for metastatic breast cancer. The approval covers Ibrance ...
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY ® (pertuzumab) 420 mg/14 mL injection for ...
SHANGHAI, April 29, 2026 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® ...
"As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...